title: Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study.
authors.affiliation: Department of Oncology, Aalborg Hospital, Aarhus University, Aalborg, Denmark.
authors.forename: Jeanne
authors.initials: J
authors.lastname: Debess
authors.forename: Jens Østergaard
authors.initials: JØ
authors.lastname: Riis
authors.forename: Malene Cramer
authors.initials: MC
authors.lastname: Engebjerg
authors.forename: Marianne
authors.initials: M
authors.lastname: Ewertz
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003071:Cognition / Q000187:drug effects*; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008137:Longitudinal Studies; D008875:Middle Aged; D009483:Neuropsychological Tests; D011788:Quality of Life; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects*; D013629:Tamoxifen / Q000009:adverse effects*
chemical_list: D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil